Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Pre-order your Brochure
Reserve your place

The successful sourcing, generation and analysis of data has fast become the backbone behind what makes a pharma company tick. 

It’s a process spreading its wings throughout the company, from drug discovery to post-approval, imposing the necessity of creating evidence for effective value demonstration to meet payor needs on all. It marks a movement in the goal posts of success for a modern-day pharma company.

This new revolution will not be forged in the belly of R&D; now is the time for those working in access, data, medical and evidence generation to take the next leap forward.

At Data, Evidence, Access 2017 over 250+ pharma executives will be brought together to plot the next stages of this movement. Pre-order the brochure to make sure you’re kept up-to-date with the latest developments. 

Be the first to see the brand new 2017 brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown

Snapshot of our presenters:

Riad Dirani
Riad Dirani

TEVA

VP Global Health Economics and Outcomes Research

John Bardi
John Bardi

Otsuka

VP Government Affairs, Advocacy & Digital Medicines Business Development

Jonathan Jarow
Jonathan Jarow

FDA

Senior Medical Director

Ana Cespedes
Ana Cespedes

EMD Serono

Head of Global Market Access & Pricing Senior Vice President

Riccardo Perfetti
Riccardo Perfetti

Sanofi

Senior Medical Officer, Vice President Global Medical Affairs, Diabetes Division

Sean McElligott
Sean McElligott

Janssen

Global Market Access Lead Dermatology

Pre-order your event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown

What our delegates say:

Supporters and Participants 2016:

Our leadership in data, evidence and market access:

 

  • Our annual meeting places in the US, Europe and Japan make up the top meeting places for data, evidence, HEOR and market access executives across the globe.
  • Collaboration beyond the norm; with key stakeholders such as payers, regulators and patients crucial to the fabric of our conferences.
  • A strictly senior audience, bringing together top industry decision-makers from across the company under one roof.”
84% of our attendees call our sessions “essential” to their future success
98% rated the program very well run
94% of our attendees say that will likely return next year

Got a question? Get in touch below!

James Mackintosh

James Mackintosh

Global project Director | eyeforpharma

Email: jmackintosh@eyeforpharma.com

Phone (US): +1800 814 3459 7163

Phone (Global): +44 (0) 207 375 7163

Ben Parkes

Ben Parkes

Head of Product | eyeforpharma

Email: bparkes@eyeforpharma.com

Phone: +44 (0) 207 422 4346

Pre-order your event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown